INHIBITION OF CELL SURVIVAL, TUMOR GROWTH AND HISTONE DEACETYLASE (HDAC) ACTIVITY BY THE DIETARY FLAVONOID LUTEOLIN IN HUMAN EPITHELIOID CANCER CELLS

被引：0
|
作者：
Iratni, R.
Attoub, S. [1 ]
Hassan, A. H. [1 ]
Vanhoecke, B. [2 ]
Gaben, A. M. [3 ]
Bracke, M. [4 ]
Al-Sultan, M.
Arafat, K.
Gespach, C. [3 ]
Petroianu, G. [1 ]
机构：
[1] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates
[2] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
[3] Univ Paris 06, INSERM, U673, U938, Paris, France
[4] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Inhibition of cell survival, tumour growth and histone deacetylase (HDAC) activity by the dietary flavonoid luteolin in human epithelioid cancer cells
    Iratni, R.
    Attoub, S.
    Hassan, A. H.
    Vanhoecke, B.
    Gaben, A. M.
    Bracke, M.
    Al-Sultan, M.
    Arafat, K.
    Gespach, C.
    Petroianu, G.
    EJC SUPPLEMENTS, 2010, 8 (05): : 63 - 63
  • [2] Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells
    Attoub, Samir
    Hassan, Ahmed H.
    Vanhoecke, Barbara
    Iratni, Rabah
    Takahashi, Takashi
    Gaben, Anne-Marie
    Bracke, Marc
    Awad, Salma
    John, Anne
    Kamalboor, Hamda Ahmed
    Al Sultan, Mahmood Ahmed
    Arafat, Kholoud
    Gespach, Christian
    Petroianu, Georg
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 651 (1-3) : 18 - 25
  • [3] Histone Deacetylase Inhibition (HDAC) Sensitizes Pancreatic Cancer Cells to TRAIL Induced Cell Death
    Chugh, R.
    Dudeja, V.
    Alsaied, O.
    Banerjee, S.
    Sangwan, V.
    Saluja, A.
    Vickers, S. M.
    PANCREAS, 2013, 42 (08) : 1344 - 1344
  • [4] Enhancing the anti-tumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition
    Chinnaiyan, P
    Varambally, S
    Tomlins, SA
    Huang, S
    Chinnaiyan, AM
    Harari, PM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 202S - 202S
  • [5] Histone deacetylase (HDAC) enzyme inhibition potentiates taxanes and doxorubicin activity in thyroid cancer cell lines
    Owonikoko, Taofeek K.
    Zhang, Guojing
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    Sun, Shi-Yong
    CANCER RESEARCH, 2010, 70
  • [6] Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel δ-lactam-based histone deacetylase (HDAC) inhibitors
    Kim, Hwan Mook
    Lee, Kiho
    Park, Bum Woo
    Ryu, Dong Kyu
    Kim, Kangjeon
    Lee, Chang Woo
    Park, Song-Kyu
    Han, Jung Whan
    Lee, Hee Yoon
    Lee, Hyun Yong
    Han, Gyoonhee
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4068 - 4070
  • [7] Histone Deacetylase Inhibition (HDAC) by Vorinostat Sensitizes Pancreatic Cancer Cells to TRAIL Induced Cell Death
    Chugh, Rohit
    Dudeja, Vikas
    Alsaied, Osama
    Banerjee, Sulagna
    Sangwan, Veena
    Saluja, Ashok
    Vickers, Selwyn M.
    GASTROENTEROLOGY, 2013, 144 (05) : S1088 - S1088
  • [8] Histone deacetylase inhibitors abrogate the levels and activity of estrogen receptor (ER) α and histone deacetylase (HDAC) 6 in human breast cancer cells (BCCs)
    Fiskus, W.
    Mohapatra, A.
    Bali, P.
    Balasis, M.
    Rao, R.
    Atadja, P.
    Wu, J.
    Bhalla, K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 177 - 177
  • [9] Induction of apoptosis and inhibition of telomerase activity by histone deacetylase inhibitors in human cancer cells
    Choi, Yung Hyun
    Park, Cheol
    Choia, Byung Tae
    Kima, Gi Young
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 67 - 67
  • [10] Interaction between histone demethylase and deacetylase may mediate activity of HDAC inhibitors in human breast cancer cells
    Huang, Yi
    Vasilatos, Shauna N.
    Boric, Lamia
    Shaw, Patrick G.
    Davidson, Nancy E.
    CANCER RESEARCH, 2011, 71
12345